[Clinical and microbiological characteristics of complicated intra-abdominal infection in Colombia: a multicenter study]

Rev Chilena Infectol. 2016 Jun;33(3):261-7. doi: 10.4067/S0716-10182016000300002.
[Article in Spanish]

Abstract

Introduction: Complicated community-acquired intra-abdominal infections (CA-cIAI) are a common cause of acute abdomen.

Objective: To identify the clinical and microbiology profile of CA-cIAI in four Colombian hospitals.

Methods: This is a prospective, descriptive study, between 08-2012 and 09-2014, including patients with CA-cIAI > 15 years. Data collected included: socio-demographic, clinical, diagnosis, and isolates of the first culture obtained aseptically during surgery with antimicrobial susceptibility.

Results: 192 patients were included, 62% men, median age 47.3 years. Co-morbidities were present in 38.4%, 13% had been hospitalized in the previous year 13%, and 9.4% had received antibiotics in the last 6 months; 44.3% were admitted for appendicitis, 17.7% for peritonitis and 16.7% for bowel perforation. CA-cIAI were assessed as moderate in 64.1% of the cases and were treated with ampicillin/sulbactam (SAM) and ertapenem. In 70.8% of cases a bacteria was isolated: 65.1% were gramnegative rods (80.0% Escherichia coli, 44.8% of them susceptible to pipercillin/tazobactam, 65.7% to SAM; 11.2 % were K.pneumoniae, 85% was susceptible for SAM; 16.7% were grampositive cocci (28.1% Streptococci viridans group). The median hospital stay was 7 days and 15.1% died.

Conclusions: E. coli, K. pneumoniae and S. viridans were the main organisms to consider in an empiric therapy for CA-cIAI and it is important to know the local epidemiology in order to choose the right antibiotic.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Anti-Infective Agents / therapeutic use
  • Colombia / epidemiology
  • Community-Acquired Infections / drug therapy
  • Community-Acquired Infections / epidemiology
  • Community-Acquired Infections / microbiology
  • Drug Resistance, Bacterial
  • Female
  • Gram-Negative Bacteria / isolation & purification*
  • Gram-Positive Bacteria / isolation & purification*
  • Humans
  • Intraabdominal Infections / drug therapy
  • Intraabdominal Infections / epidemiology*
  • Intraabdominal Infections / microbiology*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Reference Values
  • Risk Factors
  • Socioeconomic Factors
  • Statistics, Nonparametric

Substances

  • Anti-Infective Agents